Healthcare provider profile · identity verified

Cameron Moore, MD

Family Practice · NORRISTOWN, PA · NPI 1962932897

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	714	131
Gabapentin	Gabapentin	464	83
Eliquis	Apixaban	419	55
Furosemide	Furosemide	386	74
Pantoprazole Sodium	Pantoprazole Sodium	357	71
Levothyroxine Sodium	Levothyroxine Sodium	350	51
Sertraline Hcl	Sertraline Hcl	337	37
Tamsulosin Hcl	Tamsulosin Hcl	332	41
Amlodipine Besylate	Amlodipine Besylate	313	79
Metoprolol Tartrate	Metoprolol Tartrate	303	62
Famotidine	Famotidine	220	21
Trazodone Hcl	Trazodone Hcl	217	42
Oxycodone Hcl	Oxycodone Hcl	204	53
Metoprolol Succinate	Metoprolol Succinate	198	37
Carvedilol	Carvedilol	159	38
Mirtazapine	Mirtazapine	156	31
Metformin Hcl	Metformin Hcl	154	35
Xarelto	Rivaroxaban	153	14
Bumetanide	Bumetanide	143	20
Hydralazine Hcl	Hydralazine Hcl	142	27
Escitalopram Oxalate	Escitalopram Oxalate	133	27
Losartan Potassium	Losartan Potassium	132	39
Diclofenac Sodium	Diclofenac Sodium	130	58
Midodrine Hcl	Midodrine Hcl	129	25
Quetiapine Fumarate	Quetiapine Fumarate	125	25
Lisinopril	Lisinopril	124	26
Clopidogrel	Clopidogrel Bisulfate	120	23
Donepezil Hcl	Donepezil Hcl	110	27
Chlorthalidone	Chlorthalidone	101	15
Lorazepam	Lorazepam	101	30
Buspirone Hcl	Buspirone Hcl	97	17
Divalproex Sodium	Divalproex Sodium	94	16
Levetiracetam	Levetiracetam	93	21
Allopurinol	Allopurinol	90	13
Omeprazole	Omeprazole	87	26
Ezetimibe	Ezetimibe	84	14
Clonazepam	Clonazepam	82	22
Lacosamide	Lacosamide	80	14
Ondansetron Hcl	Ondansetron Hcl	75	47
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	73	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	73	21
Aripiprazole	Aripiprazole	71	14
Trulicity	Dulaglutide	66	14
Citalopram Hbr	Citalopram Hydrobromide	64	suppressed
Duloxetine Hcl	Duloxetine Hcl	64	14
Hydrochlorothiazide	Hydrochlorothiazide	64	20
Nifedipine Er	Nifedipine	64	15
Fluoxetine Hcl	Fluoxetine Hcl	62	12
Potassium Chloride	Potassium Chloride	61	19
Baclofen	Baclofen	60	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	59	21
Albuterol Sulfate Hfa	Albuterol Sulfate	55	36
Farxiga	Dapagliflozin Propanediol	55	suppressed
Prednisone	Prednisone	55	33
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	55	28
Tizanidine Hcl	Tizanidine Hcl	53	suppressed
Montelukast Sodium	Montelukast Sodium	51	15
Isosorbide Mononitrate Er	Isosorbide Mononitrate	50	suppressed
Ketoconazole	Ketoconazole	50	21
Clozapine	Clozapine	49	suppressed
Tramadol Hcl	Tramadol Hcl	49	21
Calcium Acetate	Calcium Acetate	48	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	48	25
Simvastatin	Simvastatin	48	13
Doxazosin Mesylate	Doxazosin Mesylate	46	suppressed
Levofloxacin	Levofloxacin	44	31
Venlafaxine Hcl Er	Venlafaxine Hcl	44	suppressed
Alprazolam	Alprazolam	43	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	43	22
Olanzapine	Olanzapine	42	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	42	12
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	40	21
Bupropion Xl	Bupropion Hcl	39	suppressed
Cephalexin	Cephalexin	39	21
Zenpep	Lipase/Protease/Amylase	39	suppressed
Finasteride	Finasteride	38	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	38	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	37	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	37	suppressed
Alendronate Sodium	Alendronate Sodium	36	suppressed
Fluticasone Propionate	Fluticasone Propionate	36	23
Paroxetine Hcl	Paroxetine Hcl	36	suppressed
Valsartan	Valsartan	36	suppressed
Pregabalin	Pregabalin	35	suppressed
Repaglinide	Repaglinide	33	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	32	23
Risperidone	Risperidone	32	suppressed
Lubiprostone	Lubiprostone	31	suppressed
Ozempic	Semaglutide	30	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	29	14
Januvia	Sitagliptin Phosphate	28	suppressed
Lithium Carbonate	Lithium Carbonate	28	suppressed
Mupirocin	Mupirocin	28	20
Carbidopa-Levodopa	Carbidopa/Levodopa	27	suppressed
Nystatin	Nystatin	27	21
Amiodarone Hcl	Amiodarone Hcl	26	suppressed
Diazepam	Diazepam	26	suppressed
Clonidine Hcl	Clonidine Hcl	25	suppressed
Warfarin Sodium	Warfarin Sodium	25	suppressed
Benztropine Mesylate	Benztropine Mesylate	24	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	24	12
Lansoprazole	Lansoprazole	24	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	23	suppressed
Insulin Lispro	Insulin Lispro	22	12
Pravastatin Sodium	Pravastatin Sodium	21	suppressed
Santyl	Collagenase Clostridium Hist.	21	16
Arexvy	Rsvpref3 Antigen/As01e/Pf	20	20
Atenolol	Atenolol	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Morphine Sulfate	Morphine Sulfate	20	suppressed
Entresto	Sacubitril/Valsartan	19	suppressed
Novofine Autocover	Pen Needle, Diabetic, Safety	19	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	18	suppressed
Dutasteride	Dutasteride	18	suppressed
Fluconazole	Fluconazole	18	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	18	suppressed
Jardiance	Empagliflozin	18	suppressed
Lamotrigine	Lamotrigine	18	suppressed
Nyamyc	Nystatin	18	14
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Scopolamine	Scopolamine	18	suppressed
Albuterol Sulfate	Albuterol Sulfate	17	15
Fentanyl	Fentanyl	17	suppressed
Humalog Kwikpen U-100	Insulin Lispro	17	suppressed
Incruse Ellipta	Umeclidinium Bromide	17	suppressed
Memantine Hcl	Memantine Hcl	17	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	16	suppressed
Alogliptin-Metformin	Alogliptin Benz/Metformin Hcl	15	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	15	suppressed
Isosorbide Mononitrate	Isosorbide Mononitrate	15	suppressed
Novolin N Flexpen	Insulin Nph Human Isophane	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Latanoprost	Latanoprost	14	suppressed
Megestrol Acetate	Megestrol Acetate	14	suppressed
Spironolactone	Spironolactone	14	suppressed
Acetazolamide	Acetazolamide	13	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	13	11
Colchicine	Colchicine	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Letrozole	Letrozole	13	suppressed
Mycophenolate Mofetil	Mycophenolate Mofetil	13	suppressed
Nystop	Nystatin	13	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	13	suppressed
Sps	Sodium Polystyrene Sulfon/Sorb	13	suppressed
Admelog	Insulin Lispro	12	suppressed
Amantadine	Amantadine Hcl	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Loperamide	Loperamide Hcl	12	suppressed
Mesalamine	Mesalamine	12	suppressed
Rasagiline Mesylate	Rasagiline Mesylate	12	suppressed
Admelog Solostar	Insulin Lispro	11	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Clobazam	Clobazam	11	suppressed
Digoxin	Digoxin	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Vancomycin Hcl	Vancomycin Hcl	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error